Sumitomo Pharma Revenue

Sumitomo Pharma had revenue of 119.12B JPY in the quarter ending September 30, 2025, with 32.25% growth. This brings the company's revenue in the last twelve months to 445.21B, up 29.92% year-over-year. In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B with 26.79% growth.

Revenue (ttm)

445.21B

Revenue Growth

+29.92%

P/S Ratio

2.18

Revenue / Employee

116.18M

Employees

3,832

Market Cap

969.78B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,213.71B
HOYA Corporation	892.50B
Takeda Pharmaceutical Company	4,417.00B
Daiichi Sankyo Company	1,978.88B
Otsuka Holdings	2,418.53B
Astellas Pharma	2,006.82B
Terumo	1,062.42B
Shionogi &	437.26B

Revenue Rankings